SCHEMBL1660735

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL1660732	1.00	MET (0.57)	METCA12CA7CA9CA14
	SCHEMBL1660737	1.00	MET (0.57)	METCA12CA7CA9CA14
	SCHEMBL12731827	0.90	TTR (0.65)	CA12CA7CA9CA14CA4
	SCHEMBL1660429	0.90	TNFRSF1A (0.60)	FDPSTTRNFE2L2MAOBALDH1A1
	SCHEMBL12794384	0.90	TTR (0.60)	METCA12CA7CA9CA14
	SCHEMBL11903912	0.90	TTR (0.65)	CA12CA7CA9CA14CA4
	SCHEMBL15169491	0.90	FDPS (0.59)	FDPSTTRNFE2L2MAOBALDH1A1
	SCHEMBL1660425	0.90	TNFRSF1A (0.60)	FDPSTTRNFE2L2MAOBALDH1A1
	SCHEMBL11903909	0.90	TTR (0.65)	CA12CA7CA9CA14CA4
	SCHEMBL1660427	0.90	TNFRSF1A (0.60)	FDPSTTRNFE2L2MAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.